0000950170-24-066687.txt : 20240530 0000950170-24-066687.hdr.sgml : 20240530 20240530163425 ACCESSION NUMBER: 0000950170-24-066687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maeusli Heinz Christoph CENTRAL INDEX KEY: 0001788919 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 241006013 MAIL ADDRESS: STREET 1: SCHUETZENWEG 3 CITY: ENGELBURG STATE: V8 ZIP: 9032 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 ownership.xml 4 X0508 4 2024-05-28 0001521036 Lantheus Holdings, Inc. LNTH 0001788919 Maeusli Heinz Christoph C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BUILDING BEDFORD MA 01730 true false false false true Common Stock 2024-05-28 4 M false 17481 16.17 A 49032 D Common Stock 2024-05-28 4 S false 7.326 77.71 D 41706 D Common Stock 2024-05-28 4 S false 12307 78.95 D 29399 D Common Stock 2024-05-28 4 S false 5959 79.67 D 23440 D Common Stock 2024-05-28 4 S false 100 80.29 D 23340 D Stock Option (right to buy) 16.17 2024-05-28 4 M false 17481 0.00 D 2020-06-19 2029-12-13 Common Stock 17481 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.27 to $78.12, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.28 to $79.26, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.29 to $80.22, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. /s/ Eric M. Green, attorney-in-fact 2024-05-30